112 related articles for article (PubMed ID: 190146)
1. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
Wright J; Falk L; Deinhardt F
IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G
Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325
[TBL] [Abstract][Full Text] [Related]
3. Induction of Epstein-Barr virus-associated nuclear antigen during in vitro transformation of human lymphoid cells.
Leibold W; Flanagan TD; Menezes J; Klein G
J Natl Cancer Inst; 1975 Jan; 54(1):65-8. PubMed ID: 163326
[TBL] [Abstract][Full Text] [Related]
4. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
6. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
Meerbach A; Friedrichs C; Thust R; Wutzler P
Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation.
Pope JH; Moss DJ
IARC Sci Publ (1971); 1978; (24 Pt 2):617-22. PubMed ID: 221385
[TBL] [Abstract][Full Text] [Related]
8. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
9. Induction of nuclear antigen (EBNA) synthesis without transformation in human cord lymphocytes by P3HR-1 strain of Epstein-Barr virus.
Yamamoto N; Hinuma Y
Virology; 1978 Sep; 89(2):623-6. PubMed ID: 213884
[No Abstract] [Full Text] [Related]
10. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
zur Hausen H; Fresen KO
IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
Menezes J; Jondal M; Leibold W; Dorval G
Infect Immun; 1976 Feb; 13(2):303-10. PubMed ID: 177360
[TBL] [Abstract][Full Text] [Related]
12. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
13. [In vitro immunization of human lymphocytes with Epstein-Barr virus capsid antigen].
Kulikov VV; Krivonos AV; Krasheninnikov ME; Borisova OV; Kal'nov SL
Biull Eksp Biol Med; 1991 Jan; 111(1):62-4. PubMed ID: 1647234
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
15. EBNA-2 -deleted Epstein-Barr virus from P3HR-1 can infect rabbits with lower efficiency than prototype Epstein-Barr virus from B95-8.
Sano H; Nagata K; Kato K; Kanai K; Yamamoto K; Okuno K; Kuwamoto S; Higaki-Mori H; Sugihara H; Kato M; Murakami I; Kanzaki S; Hayashi K
Intervirology; 2013; 56(2):114-21. PubMed ID: 23295915
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
Takada K; Osato T
Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Epstein-Barr virus. IV. Induction of a specific antigen by EBV from two transformed marmoset cell lines in Ramos cells.
Fresen KO; Cho MS; zur Hausen H
Int J Cancer; 1978 Aug; 22(2):160-5. PubMed ID: 81181
[TBL] [Abstract][Full Text] [Related]
18. Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease.
Rabin H; Neubauer RH; Hopkins RF; Dzhikidze EK; Shevtsova ZV; Lapin BA
Intervirology; 1977; 8(4):240-9. PubMed ID: 194867
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes.
Steinitz M; Bakács T; Klein G
Int J Cancer; 1978 Sep; 22(3):251-7. PubMed ID: 212371
[TBL] [Abstract][Full Text] [Related]
20. Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.
Margalith M; Manor D; Agranat I; Bentor Y; Gelfand T; Goldblum N
Cancer Biochem Biophys; 1980; 4(3):137-43. PubMed ID: 6254633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
